Literature DB >> 11243899

Association of SV40 with human tumours.

B Jasani1, A Cristaudo, S A Emri, A F Gazdar, A Gibbs, B Krynska, C Miller, L Mutti, C Radu, M Tognon, A Procopio.   

Abstract

SV40 was discovered as a contaminant of poliovirus vaccines that were inadvertently administered to millions of people in Europe and the United States between 1955 and 1963. Shortly afterwards, SV40 was proven to be oncogenic in rodents and capable of transforming human and animal cells in vitro. The possibility that SV40 might cause tumours in humans thus became a subject of scientific and public interest and scrutiny. However, largely due to a lack of significant epidemiological evidence, interest in assessing SV40's potential carcinogenic role in humans diminished. Recently, many laboratories have reported the presence of SV40-like DNA in a high proportion of human mesotheliomas, ependymomas and osteosarcoma (the three main types of tumours caused by virus in hamsters), renewing the question whether SV40 might be a human tumour virus. Molecular data from these studies are reviewed to re-evaluate the potential role of SV40 as a human carcinogen. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243899     DOI: 10.1006/scbi.2000.0346

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  25 in total

1.  Simian virus 40 infection of humans.

Authors:  Robert L Garcea; Michael J Imperiale
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Immunodetection of SV40 T/t-antigens in human osteosrcoma in a series of Tunisian patients.

Authors:  S Ziadi; H Boughamoura; M Ben Maitig; R Ben Gacem; S Mestiri; L Chaabani; M Trimeche
Journal:  Pathol Oncol Res       Date:  2012-07       Impact factor: 3.201

3.  Immunolocalization of caveolin-1 in rat and human mesothelium.

Authors:  Christopher J von Ruhland; Lee Campbell; Mark Gumbleton; Bharat Jasani; Geoffrey R Newman
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

4.  Occurrence of TRGV-BJ hybrid gene in SV40-transformed fibroblast cell lines.

Authors:  L P G D'Arce; C L Bassi; A L Fachin; G A S Passos; E T Sakamoto-Hojo
Journal:  Genetica       Date:  2009-01-14       Impact factor: 1.082

Review 5.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Transformation of SV40-immortalized human uroepithelial cells by 3-methylcholanthrene increases IFN- and Large T Antigen-induced transcripts.

Authors:  Lynn M Crosby; Tanya M Moore; Michael George; Lawrence W Yoon; Marilyn J Easton; Hong Ni; Kevin T Morgan; Anthony B DeAngelo
Journal:  Cancer Cell Int       Date:  2010-02-23       Impact factor: 5.722

Review 7.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

8.  Polyomavirus shedding in the stool of healthy adults.

Authors:  John A Vanchiere; Suhaib Abudayyeh; Christina M Copeland; Lee B Lu; David Y Graham; Janet S Butel
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

9.  Reactivation of infectious simian virus 40 from normal human tissues.

Authors:  Giuseppe Barbanti-Brodano; Fernanda Martini; Alfredo Corallini; Lorena Lazzarin; Cecilia Trabanelli; Beatrice Vignocchi; Nilla Calza; Laura Iaccheri; Cristina Morelli; Mauro Tognon
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

10.  A safety-modified SV40 Tag developed for human cancer immunotherapy.

Authors:  Stephanie S Tseng-Rogenski; Mohamed S Arredouani; June F Escara-Wilke; Yilin C Neeley; Michael J Imperiale; Martin G Sanda
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.